We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

145 hedge funds and large institutions have $1.11B invested in Alder Biopharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 38 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $2.78M | Put options by funds: $642K

71% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 38

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

9% less funds holding

Funds holding: 159 → 145 (-14)

36% less capital invested

Capital invested by funds: $1.73B → $1.11B (-$620M)

43% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 30

Holders
145
Holders Change
-14
Holders Change %
-8.81%
% of All Funds
3.63%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
17
Increased
65
Reduced
38
Closed
30
Calls
$2.78M
Puts
$642K
Net Calls
+$2.14M
Net Calls Change
+$10.3M

Top Buyers

1
PHS
PFM Health Sciences
California
+$23.6M
2
JHIU
Janus Henderson Investors US
Colorado
+$9.57M
3
CCP
Clough Capital Partners
Massachusetts
+$7.65M
4
BFA
BlackRock Fund Advisors
California
+$7.24M
5
State Street
State Street
Massachusetts
+$6.97M

Top Sellers

1
SIG
Senator Investment Group
New York
-$32.8M
2
Citadel Advisors
Citadel Advisors
Florida
-$20.8M
3
Marshall Wace
Marshall Wace
United Kingdom
-$12.2M
4
Asset Management One
Asset Management One
Japan
-$9.69M
5
DCM
Driehaus Capital Management
Illinois
-$7.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
126
BNP Paribas Financial Markets
France
$30.9K -$61.3K -2,356 -61%
NIT
127
NumerixS Investment Technologies
British Columbia, Canada
$27K -$185K -7,100 -85%
Fifth Third Bancorp
128
Fifth Third Bancorp
Ohio
$23K -$21.7K -836 -43%
SEI Investments
129
SEI Investments
Pennsylvania
$22K +$78 +3 +0.3%
Creative Planning
130
Creative Planning
Kansas
$21K -$3.9K -150 -13%
Zurich Cantonal Bank
131
Zurich Cantonal Bank
Switzerland
$21K – – –
Nisa Investment Advisors
132
Nisa Investment Advisors
Missouri
$12K +$15.6K +600 New
DADC
133
D.A. Davidson & Co
Montana
$10K +$13K +500 New
AG
134
Advisor Group
Arizona
$9K +$6.5K +250 +137%
LTFS
135
Ladenburg Thalmann Financial Services
Florida
$7K – – –
Envestnet Asset Management
136
Envestnet Asset Management
Illinois
$7K +$9.05K +348 New
Bank of Montreal
137
Bank of Montreal
Ontario, Canada
$4K – – –
BBHC
138
Brown Brothers Harriman & Co
New York
$2K – – –
CHP
139
Cable Hill Partners
Oregon
$1K -$4.71K -181 -88%
TWA
140
TCI Wealth Advisors
Arizona
$1K – – –
US Bancorp
141
US Bancorp
Minnesota
$1K +$1.09K +42 New
GRP
142
Global Retirement Partners
California
$1K +$1.17K +45 New
SIG
143
Senator Investment Group
New York
– -$32.8M -1,000,000 Closed
Asset Management One
144
Asset Management One
Japan
– -$9.69M -309,500 Closed
DCM
145
Driehaus Capital Management
Illinois
– -$7.63M -232,874 Closed
State of Wisconsin Investment Board
146
State of Wisconsin Investment Board
Wisconsin
– -$4.98M -152,000 Closed
SFM
147
Sphera Funds Management
Israel
– -$3.69M -112,500 Closed
OAM
148
Oxford Asset Management
United Kingdom
– -$3.31M -100,864 Closed
ACM
149
Atika Capital Management
New York
– -$2.88M -88,000 Closed
NIP
150
Nicholas Investment Partners
California
– -$2.27M -69,103 Closed
3 4 5
6
7

ALDR Hedge Fund Activity: Q4 2016 in Review

145 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q4 2016, worth a combined $1.11B — down 36% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of ALDR and 17 opened new positions — a net loss of 13 holders — while 38 trimmed existing stakes and 65 added.

The largest buyer was PFM Health Sciences, adding an estimated $23.6M. The largest seller was Senator Investment Group, exiting entirely with an estimated $32.8M sold.

  • 145 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q4 2016, down from 159 in Q3 2016.
  • Funds reported $1.11B of Alder Biopharmaceuticals stock for Q4 2016, down 36% quarter-over-quarter.
  • 17 funds opened new Alder Biopharmaceuticals positions in Q4 2016 and 30 closed out, a net change of -13 holders.
  • The largest Alder Biopharmaceuticals buyer in Q4 2016 was PFM Health Sciences, an estimated $23.6M added.
  • The largest Alder Biopharmaceuticals seller in Q4 2016 was Senator Investment Group, an estimated $32.8M sold.

Based on aggregated 13F filings for Q4 2016.